Xtant Medical Holdings, Inc.

AMEX:XTNT

Medical - Devices

Healthcare
$0.36 -0.16%

-$0.00 today

Market cap
$50.37M
Beta
-0.17
P/E (TTM)
33.4
EPS (TTM)
$0.01
52W Low $0.40High $0.95

Volume 0.16M

Average 0.16M

XTNT EBITDA Margin

EBITDA as a percentage of revenue.

Xtant Medical Holdings, Inc.AMEX: XTNT

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin narrows to -9.2%

EBITDA Margin was -9.2% in Q1 FY2026, down 15.8 pp from a year earlier. On a trailing-twelve-month basis it was 9.7%, up 12.3 pp year over year. Over 3 fiscal years it widened by 21.2 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 3 analysts of 4.6% for the fiscal year ending Dec 2026, down from 11.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-9.2%-22.0 pp QoQ
Last fiscal yearDec 2025
11.9%+18.6 pp YoY
LTMMar 2026
9.7%+12.3 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-15.8 pp-23.9 pp-8.2 pp
1 year+18.6 pp-7.3 pp-25.9 pp
3 years+21.2 pp-2.8 pp-24.0 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
11.9%
Year-over-year change
+18.6pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How XTNT compares with its peers on the latest reported figures

  • XTNT's LTM Mar 2026 EBITDA Margin of 9.7% is the 2nd highest of the 6 companies compared; the peer median is -52.1%.
  • Its year-over-year change of +12.3 pp is the 4th highest of 6, against a peer median of +18.1 pp.
  • Over three fiscal years its change of +21.2 pp compares with a peer median of +40.8 pp.
XTNT Competitors Peer median
EBITDA Margin for XTNT and competitors
Company Period LTM level YoY 3-year change
FONRFONAR CorporationLTM Mar 202615.1% -3.2 pp-10.6 pp
XTNTXtant Medical Holdings, Inc.LTM Mar 20269.7% +12.3 pp+21.2 pp
APYXApyx Medical CorporationLTM Mar 2026-4.4% +24.0 pp+40.8 pp
RCELAVITA Medical, Inc.LTM Mar 2026-52.1% +18.1 pp+20.4 pp
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026-131.2% +8.9 pp+214.5 pp
LUCDLucid Diagnostics Inc.LTM Mar 2026-859.3% +600.4 pp+13170.1 pp
VANIVivani Medical, Inc.FY2025— ——
EXOZeXoZymes, Inc.FY2025— ——
Peer median (excluding XTNT) -52.1%+18.1 pp+40.8 pp

Competitors are the stored peer set for XTNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue55.26M57.97M91.3M117.27M133.93M
Cost of Revenue22.77M25.83M35.84M49.05M49.65M
Gross Profit32.49M32.14M55.47M68.22M84.27M
Gross Margin58.8%55.4%60.8%58.2%62.9%
Research & Development870K915K1.34M2.39M2.1M
Selling, General & Admin35.47M37.98M64.29M77.91M74.89M
Operating Expenses36.34M38.89M65.63M80.29M76.99M
Depreciation & Amortization1.34M1.3M3.17M4.22M5.22M
EBITDA(2.51M)(5.43M)5.08M(7.88M)15.9M
EBITDA Margin-4.5%-9.4%5.6%-6.7%11.9%
Operating Income(3.85M)(6.76M)(10.16M)(12.07M)7.28M
Operating Margin-7.0%-11.7%-11.1%-10.3%5.4%
Interest Income031K149K094K
Interest Expense995K1.69M2.94M4.16M3.67M
Other Income / Expenses(995K)(1.66M)9.12M(4.19M)(283K)
Income Before Tax(4.85M)(8.42M)(1.04M)(16.26M)7M
Pre-Tax Margin-8.8%-14.5%-1.1%-13.9%5.2%
Income Tax Expense069K(1.7M)187K2.03M
Net Income(4.85M)(8.49M)660K(16.45M)4.97M
Net Margin-8.8%-14.6%0.7%-14.0%3.7%
EPS (Basic)(0.06)(0.09)0.01(0.12)0.04
EPS (Diluted)(0.06)(0.09)0.01(0.12)0.03
Weighted Avg Shares85.46M94.09M119.09M133.67M139.53M
Weighted Avg Shares (Diluted)85.46M94.09M126.79M133.67M150.04M

Xtant Medical Holdings, Inc.

AMEX:XTNT

Intrinsic Alpha fair value

Locked

Current Price

$0.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.